Scientists Create First Vascularized Skin Organoids with Immune Cells from Stem Cells

Scientists have achieved a major breakthrough in tissue engineering by creating the first vascularized skin organoids that contain resident immune cell populations, addressing a critical gap in current skin models used for research and therapy.

The research team from the University of Queensland developed these complex organoids by combining human induced pluripotent stem cell-derived skin organoids with vascular organoids at day 18 of development, mimicking natural human embryonic timing. They tested two approaches: incorporating endothelial colony forming cells (ECFCs) alone, and integrating complete vascular organoids containing multiple cell types.

The vascular organoid approach proved superior, generating fully functional vascularized skin organoids (VSKOs) maintained for 115 days. Flow cytometry analysis revealed successful integration of endothelial cells, mural cells (pericytes and smooth muscle cells), hematopoietic cells, and mesenchymal cells from the vascular component into the skin tissue. Importantly, the organoids developed resident immune populations including macrophages, Langerhans cells, and neutrophils - cell types crucial for skin immunity and wound healing.

Immunohistochemical analysis confirmed proper tissue architecture with stratified epidermis, dermal layers, hair follicles, and functional blood vessel networks. The vascularized organoids showed enhanced epidermal stratification and hair follicle development compared to non-vascularized controls, demonstrating the importance of blood supply for proper skin development.

This advancement represents the first successful creation of a vascularized, immune-competent skin model derived entirely from human stem cells. The technology offers transformative applications for studying inflammatory skin diseases, testing therapeutics, and developing improved skin grafts with pre-existing blood supply to enhance transplant success rates.